Gary Ruoff, DO
Family Medicine · Traverse City, MINPI 1073608568
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,505 of the $5,657 with a category attached, or 79.6%. Teva Pharmaceuticals USA, Inc. accounts for 88.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $5,089 and has fallen 99.2% since, to $41 in 2025. Among family medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $235.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$5K
- AbbVie$483
- Novartis$55
- Takeda Pharmaceuticals U.S.A., Inc.$54
- GSK$44
- Sunovion Pharmaceuticals Inc.$24
- plus $12 from 1 others
Across 2 payments — averaging $3075.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$6K
What the payments were for
- Consulting fees$4,50580%
- Speaking & faculty fees$4007%
- Travel & lodging$1703%
- Food & beverage$54110%
- Education$411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $4,986 |
| AbbVie(2 entities) | 5 | $483 |
| Novartis | 4 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $54 |
| GSK | 3 | $44 |
| Sunovion Pharmaceuticals Inc. | 3 | $24 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AJOVY$4,940
How this compares
$5,657 in reported general payments places this provider in the 90th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 95 | $109,584 |
| Humira(Cf) PenAdalimumab | 13 | $92,694 |
| JardianceEmpagliflozin | 77 | $82,908 |
| OzempicSemaglutide | 54 | $67,264 |
| MounjaroTirzepatide | 37 | $58,671 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $45,344 |
| TrulicityDulaglutide | 17 | $29,573 |
| XareltoRivaroxaban | 28 | $28,412 |
| FarxigaDapagliflozin Propanediol | 21 | $23,181 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $13,803 |
| Atorvastatin Calcium | 439 | $6,842 |
| AliskirenAliskiren Hemifumarate | 12 | $4,822 |
| Omeprazole | 250 | $4,258 |
| Levothyroxine Sodium | 222 | $4,158 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $3,471 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $44 | $45,34435 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Traverse City
- Rafay BaigTraverse City$48K
- Kathryn ShafferTraverse City$20K
- Michael CarrollTraverse City$18K
- David BestTraverse City$16K
- Nathan SailorTraverse City$16K
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.